May 16, 2024
Boehringer Ingelheim unveils its first global sustainability publication ‘Imagine’
January 04, 2024
FDA grants breakthrough status to schizophrenia treatment
December 11, 2023
EU approves Jardiance® for treatment of type 2 diabetes in children aged 10 years and above
December 07, 2023
Boehringer Ingelheim Venture Fund invests in the development of precision antimicrobials
November 15, 2023
Update on Israel and the Palestine Territories
October 16, 2023
Addressing healthcare disparities through collaborative innovation and drone delivery
September 27, 2023
World-renowned top scientists and companies take the stage at Boehringer Ingelheim’s second Transforming Science Day
September 21, 2023